The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the intraoperative type ia endoleak, (resolved with a bare metal stent and ballooning), and dissection below right renal artery, (resolved by implanting two additional non-endologix stents) were confirmed.This is consistent with the reported adverse event/incident.The most likely causation for the intra-operative aorta dissection was due to over ballooning (user related) after the implant of non-endologix bare metal stent (to resolve the type ia endoleak).As the type ia endoleak was resolved intraoperatively, it is not a patient clinical harm.Procedure related harms, device, user, procedure, or anatomy relatedness of this complaint could not be determined for the death with the medical records available for review.The final patient status was reported as expired on (b)(6) 2021.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
|